5-aza-2′-deoxycytidine, a DNA methyltransferase inhibitor, reversed hypermethylation at the MMP9 promoter (hypermethylation of a promoter represses gene transcription) and concomitantly induced MMP9 gene expression in lymphoma cell lines [24]. Here, MMP9 is linked to lymphoma.